ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NASH market forecast to be worth $18.3bn by 2026 pharmaceutical-technology
January 03, 2019Due to increasing rates of obesity and diabetes, non-alcoholic steatohepatitis (NASH), a chronic inflammatory liver disease, is becoming increasingly prevalent.
Pharma Sources Insight January 2025
